Safety profile of risankizumab in crohn's disease patients by age: post-hoc analysis of the phase 3 advance, motivate, and fortify studiesJean Frederic Colombel,Silvio Danese,Naomi Martin,Kristina Kligys,Javier A. Zambrano,W. Rachel Duan,Yafei Zhang,Willem Koetse,Remo Panaccione,Geert D'Haens,Marc Ferrante,Laurent Peyrin-BirouletGASTROENTEROLOGY（2023）引用 0|浏览0暂无评分关键词risankizumab,crohns,post-hocAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
